Interspond expedites the study start-up process for clinical drug studies.Interspond offers economies of scale with a solid industry reputation.Interspond has collectively met or exceeded enrollment goals 90% of the time.
Interspond works quickly to identify study opportunities for site participation.To the Interspond home page.About Interspond including background information on our expertise, case histories, clients and the therapuetic areas in which Interspond has worked.Services provided by Interspond for Sponsors & CRO's, and for Investigators and Sites.RxPaying™ is an exclusive service offered by Interspond, LLC that benefits CRO's, Sponsors, investigative Sites and Patients.How to contact Interspond, LLC for your next clincal study.

Interspond simplifies the study start-up process and offers economies of scale. Interspond accelerates the study start-up process.

RxPaying™ is an electronic payment solution that centralizes patient reimbursement and increases patient retention.
Interspond's exclusive RxPaying™ electronic patient reimbursement debit card saves time for CRO's. Sponsors, Investigators and study Sites.

The RxPaying™ electronic patient reimbursement debit card simplifies the patient reimbursement process and increases patient retention. RxPaying™ offers electronic payment solutions for the clinical research industry. RxPaying™ streamlines and simplifies the process of administering investigator grants, paying invoices to sites, and reimbursing patients for participation in clinical research studies.

These electronic payment solutions allow patients to have instant access to their funds and sites to receive automatic payment based on an EDC data entry trigger. Sites will no longer have to process and track reimbursements to patients or wait several months for their investigator grant payment.

Electronic Grant Payments Help Sites Better Manage Cash Flow

Investigator grant payments are processed automatically for completed visits confirmed by EDC data entry on a daily basis. Sites are able to better manage their business due to adequate cash flow and focus on the task of enrolling patients. It is possible sites will enter the data into the EDC system sooner knowing they will be paid automatically upon data entry.

Use of the RxPaying™ Debit Card Helps Ensure Higher Patient Participation and Retention

The use of the RxPaying™ debit card centralizes the process of patient reimbursement for clinical studies as a whole and provides unique benefits to patients, investigative sites and sponsors.

The RxPaying™ Debit card allows patients immediate access to their funds. They can use it to purchase items, request cash back from a purchase, or get cash from an ATM.

Advantages to using RxPaying™:

Investigator Grants:
  • Automatic process eliminating double entry. Reduces the potential for human error
  • Incentive for sites to enter their data into EDC system sooner knowing it will trigger payment
  • Sponsors get their data sooner than current timelines
  • Solves the current problem of slow grant payments
Debit Card:
  • Instant availability of funds to patient
  • One card used throughout the study which is reloadable for every visit
  • Used everywhere debit cards are accepted
  • Patients can request cash back from purchases or access cash from an ATM
For Sponsors and CROs:
  • Automated seamless process
  • Centralized process for patient reimbursement for entire study
  • Cost effective service
  • Higher patient retention potential
  • Detailed reports of payments
For Investigators and Sites:
  • Eliminates the hassle of tracking payments and cutting checks to patients
  • Will no longer have to front money to patients
  • Will no longer have to wait for reimbursement from Sponsor
  • Web based portal for ease of use
  • Detailed reports for verification of payment



A trial management organization for the pharmaceutial and biotechnology industries.Interspond, LLC provides timely indentification of qualified investigative sites and expedites the study start-up process.A trial management organization for phase 1 through phase 4 studies.


© 2007 Interspond LLC - Verona, Wisconsin - (608) 541-8226